0001127602-22-013535.txt : 20220507 0001127602-22-013535.hdr.sgml : 20220506 20220505171923 ACCESSION NUMBER: 0001127602-22-013535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220503 FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karachun Rita A CENTRAL INDEX KEY: 0001601572 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 22897744 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-03 0000310158 Merck & Co., Inc. MRK 0001601572 Karachun Rita A MERCK & CO., INC. 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 1 Sr. VP Fince-Global Controller Common Stock 2022-05-04 4 M 0 949 87.10 A 41428.972 D Common Stock 2022-05-04 4 F 0 326 87.10 D 41102.972 D Stock Option (Right to Buy) 87.10 2022-05-03 4 A 0 13592 0 A 2023-05-03 2032-05-02 Common Stock 13592 13592 D Restricted Stock Unit 2022-05-03 4 A 0 2411 0 A 2023-05-03 2025-05-03 Common Stock 2411 2411 D Restricted Stock Unit 2022-05-04 4 M 0 949 0 D 2022-05-04 2024-05-04 Common Stock 949 1900 D Holdings include shares acquired in dividend reinvestment transactions. The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025. Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2023, 5/3/2024 and 5/3/2025. Holdings reflect the adjustments that occurred as of June 2, 2021 in connection with the Organon & Co. ("Organon") spin-off as described in the registration statement on Form 10 filed with the SEC by Organon (the "Form 10"). As reported in the Form 10, all Merck restricted stock unit awards outstanding as of immediately prior to the distribution date were converted on the distribution date into adjusted Merck awards for Merck employees to preserve the same intrinsic value and general terms and conditions (including vesting) as were in place immediately prior to the adjustments. These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. /s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun 2022-05-05